The phenotype of B cells that respond to vaccination with the purified pneumococcal polysaccharide (PPS) has been a topic of debate. We have recently identified the phenotype of cells from healthy young volunteers as CD27 + IgM + B cells. However, the PPS-responding B-cell population has not yet been identified in high-risk populations, such as elderly individuals. Previous studies have shown that elderly individuals have a lower percentage of immunoglobulin M memory B cells than healthy young adults. In this study, we directly characterized the phenotype of PPS-specific B cells before and after vaccination with PPS vaccine (PPV) in elderly adults, using fluorescently labeled PPS14 and PPS23F. In contrast to our observations in healthy young volunteers, the PPS-responding B-cell population consisted primarily of switched memory (CD27 + IgM − ) B cells. In concurrence with these findings, postvaccination immunoglobulin M concentrations were not significantly increased in this population, and the opsonophagocytic response was decreased, compared with that in young adults. These findings identify a significant shift in the phenotype of the B-cell population in response to PPV among elderly individuals.
Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide. The groups at highest risk are young children, elderly adults (age, >65 years), and immunocompromised individuals. Despite the high efficacy of the pneumococcal polysaccharide vaccine (PPV) in young adults, it is less protective in populations at highest risk for invasive pneumococcal disease, including elderly individuals [1] [2] [3] [4] .
After vaccination with PPV, elderly individuals produce anti-PPS immunoglobulin G (IgG) antibodies (Abs) in concentrations similar to those produced by young adults [5, 6] . However, decreased opsonophagocytic activity (OPA), restricted variable gene use, and lower immunoglobulin M (IgM) concentrations may all play a role in the vaccine's decreased efficacy [7] [8] [9] . The underlying cause of these differences remains to be elucidated.
The phenotype of the B-lymphocyte population responsible for the immune response to PPV has been controversial. After stimulation in vitro, anti-PPS Abs are secreted mainly by switched memory cells (CD27 + IgM − ) and are predominantly IgG and immunoglobulin A (IgA) [10] [11] [12] . However, individuals with reduced numbers of or no CD27 + IgM + B cells respond poorly to PPV and are more vulnerable to infections caused by encapsulated bacteria [7, 9, [13] [14] [15] [16] .
We recently described a highly significant increase in the CD27 + IgM + PPS-specific B-cell population 7
days after vaccination in healthy young adults [17] . The specific aim of this study was to identify the phenotype, using CD19, CD27, and IgM markers, and to enumerate PPS-specific B cells in elderly individuals.
Our study demonstrates a significant change in the phenotype of PPS-responding B cells, PPS-specific IgM, and OPA after vaccination in elderly individuals as compared to young adults. These findings may help explain the decreased efficacy of the purified PPV in individuals older than 65 years.
METHODS

Human Volunteers
Fourteen 
Labeling of PPS14 and PPS23F
Conjugation of PPS14 to cascade blue (CB) ethylenediamine (Invitrogen, catalog no. C-621) or of PPS23F to 5-(4,6-dichlorotriazinyl) aminofluorescein (5-DTAF; Sigma-Aldrich, catalog no. 36565) was carried out as previously described [17] .
PPS Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA was performed to examine anti-PPS-specific human Abs in all volunteers. The PPS ELISA used in this study is modified version of the World Health Organization assay [18] . All steps were performed as reported previously [17] .
OPA Assay
The OPA assay was performed as previously described [19, 20] . Briefly, S. pneumoniae serotypes 14 and 23F were incubated with serially diluted heat-inactivated sera. Newborn rabbit serum (Pel-Freez, Brown Deer, WI) was added as a source of complement. Differentiated HL-60 cells were added at an E:T ratio of 400:1. Sera were tested in duplicate. Results were obtained using the Opsotiter1 software program (University of Alabama-Birmingham).
Flow Cytometry
To determine the phenotype of B cells responding to vaccination, peripheral blood mononuclear cells (PBMCs) were collected from immunized volunteers 0, 7, and 30 days after vaccination. After Ficoll-gradient centrifugation and washing, cells were resuspended in FACS buffer ( phosphate-buffered saline, 0.1% fetal calf serum, and 2 mM ethylenediaminetetraacetic acid). Before staining, cells were absorbed with 10 μg/mL cell wall polysaccharide (Statens Serum Institute; MiraVista Diagnostics, Indianapolis, IN) and PPS22F (American Type Culture Collection) to reduce nonspecific binding [21] . B lymphocytes were labeled with 10 μg/mL of either PPS14-CB or PPS23F- ).
Statistical Analysis
Geometric mean concentrations of IgG, IgM, and IgA and flow cell numbers specific to PPS14 and PPS23F were calculated for each group. Correlation between 2 groups was examined using the Pearson correlation coefficient. Comparison between 2-group values was performed using an unpaired t test. P values of < .05 were considered to be significant.
RESULTS
Serum Ab Titers in Elderly Individuals Increased After Vaccination
To study the PPS-specific immune response to PPV in elderly individuals, we obtained sera before and 30 days after vaccination and measured Ab responses to pneumococcal serotypes 14 and 23F. Elderly donors had a significant rise in the concentration of PPS14-specific IgG, from 0-16.2 µg/mL before vaccination to 14.8-86.9 µg/mL after vaccination (P < .001). There was no significant increase in the PPS14-specific IgM or IgA Ab concentrations after vaccination. Similarly, postvaccination IgG responses to PPS23F were significantly increased as compared to those in prevaccination sera (range, 0-2.2 µg/mL vs 0.5-15 µg/mL; P < .004). There was a significant increase in PPS23F-specific IgM (P < .03) but not in PPS23F-specific IgA after vaccination (data not shown). In our sample population, there was an increase in IgG concentration for both PPS14 and PPS23F and an increase in IgM concentration for PPS23F only after vaccination, compared with before vaccination. All donors but 1 displayed an increase in the serotype-specific IgG Ab response for PPS14.
Serum Opsonophagocytic Ab Titers in Elderly Individuals Increased After Vaccination
The functional or opsonophagocytic response of serum Ab obtained before and 30 days after vaccination against both serotype 14 and 23F PPS was determined for all donors. Data are reported as opsonophagocytic Ab titers, defined as the Ab dilution required to obtain 50% opsonophagocytic killing by differentiated HL-60 cells. Overall, postvaccination sera showed a significant increase in opsonophagocytic Ab titers against both serotype 14 and serotype 23F as compared to prevaccination sera (P < .01). All donors except 3 demonstrated an increase of ≥2-fold in opsonophagocytic Ab titers after vaccination. There was good correlation between the anti-PPS IgG concentration and the opsonophagocytic Ab titer (r 2 = 0.8 and P = .0025 for PPS14; r 2 = 0.863 and P = .0008 for PPS23F) but not between the IgM concentration and the opsonophagocytic Ab titer (data not shown).
Unselected B-Lymphocyte Counts Are Decreased in Peripheral Blood From Elderly Individuals
Peripheral blood lymphocytes (PBLs) were isolated, and the percentage and absolute number of B cells were determined for elderly individuals and compared to data we obtained from our previous study involving young adults ( Table 1 ). The percentage of B cells in elderly individuals was 7.84%, with a mean absolute B cell count (±standard error of the mean [SEM]) of 149 300±40 950 cells/mL. These values were significantly lower than those for young adults (18.67% and 368 100±65 400 cells/mL, respectively; P < .01 for both comparisons).
Phenotype of PPS-Specific B Lymphocytes Isolated From PBMCs From Elderly Individuals
Before vaccination and on day 7 after vaccination, PBMCs were isolated, labeled, and subjected to flow cytometry. The phenotype of pre-and postvaccination PPS-specific B cells was compared to the phenotypes of unselected B cells and of B cells from our historical young adult controls [17] . Figure 1 ). On day 7 after vaccination, the percentage of PPS-selected B cells increased significantly (4.60% for PPS14 and 4.65% for PPS23F; Table 2 ). The majority of postvaccination PPS-labeled B cells were memory B cells (CD27 + ), accounting for 70.4% for PPS14 and 78.7% for PPS23F (Figure 1 
Phenotype of PPS-Specific B Lymphocytes Isolated From PBMCs From Elderly Individuals Versus That Among B Lymphocytes From Healthy Young Adults
In our previous study [17] , we identified the phenotype of B cells responding to PPV 7 days after vaccination in healthy young adults (age, 18-30 years). In prevaccination PBMCs, 1.1% and 1.2% of B cells before immunization and 5.0% and 4.2% after immunization were labeled with PPS14 and PPS23F, respectively. In elderly individuals, the pre-and postvaccination percentages of PPS14-and PPS23F-labeled B cells were similar, namely 1.85% and 2.01%, respectively, before immunization and 4.60% and 4.65%, respectively, after immunization (Table 2 ). Figure 2 compares the 4 B-cell populations-naive, class-switched, CD27 + IgM + , and switched memory-isolated from elderly individuals to those isolated from healthy young adults in our previous study [17] . 
DISCUSSION
We recently determined that the PPV-responding population in healthy young adults consisted of CD27 + IgM + B cells [17] .
However, the PPV-responding B-cell subset for at-risk populations such as elderly individuals had not been previously analyzed. The goal of this study was to characterize the phenotype of responding B cells in elderly individuals after PPV vaccination. We analyzed the immune response to PPS14 and PPS23F because both are present in PPV23; PPS14 represents an immunogenic serotype that elicits excellent Ab responses, whereas PPV23F represents a poorly immunogenic serotype.
To ascertain the immunocompetence of our elderly volunteers and their ability to respond to PPV, we studied pre-and postvaccination PPS-specific immunoglobulin concentration and OPA. Although all but 1 individual displayed a significant increase in anti-PPS IgG concentration after vaccination, the IgM concentration increased significantly only in response to PPS23F. This is in stark contrast to the results obtained in healthy young adults, who demonstrated a significant increase in all immunoglobulin isotypes after vaccination for both PPSs [17] . Several studies have documented an association between decreased efficacy and increased age among PPV recipients [2, 22] . Despite adequate Ab concentrations, the OPA is markedly decreased in elderly individuals [8, [23] [24] [25] . Decreased vaccine efficacy is likely related to alterations in functional Ab activity and specificity rather than to IgG Ab concentrations [24, 26] . Several investigators [8, 9, 27] recently reported a significant reduction in the PPS-specific IgM response in elderly individuals. Moreover, depletion of IgM from serum significantly reduced OPA against PPS14 and PPS23F. Others have made similar observations in the response to encapsulated organisms, emphasizing the important role of IgM antibodies in protective immunity [23, 24, [28] [29] [30] . The results of our Ab and opsonophagocytic studies are thus similar to those of previous studies that demonstrated a loss of IgM Ab and OPA in elderly individuals.
We used fluorescently labeled PPS in conjunction with flow cytometry for identification and analysis of PPS-specific B lymphocytes. We have previously shown that fluorescently labeled PPSs retain their functional activity and specificity [17] . The use of directly labeled PPS minimizes potential cross-reactivity with linking agents, resulting in lower background binding and more-accurate phenotype analysis. [7, 31] . In concordance with our findings, Colonna-Romano et al and others reported no change in the IgM + CD27 + B-cell percentage with increased age [32, 33] .
However, a significant reduction in the absolute number of B cells was reported [33] , resulting in decreased numbers of B cells in all phenotype subpopulations. The preimmunization PPS-selected B-cell population, in response to both PPSs, consisted predominantly of memory B cells, divided between IgM + CD27 + and switched memory Bcell populations, with a concomitant decrease in the fraction of naive B cells. In contrast, the preimmune PPS-labeled B-cell fraction in young adults closely resembled the unselected B-cell phenotype [17] , with a predominance of naive B cells. The shift in phenotype from unselected to preimmunization PPS-labeled B cells and from the PPS-specific B-cell phenotype in young individuals to the PPS-specific B-cell phenotype in elderly individuals may reflect the magnitude of prior contact, either through natural exposure or vaccination. It should be noted that Ab concentration, opsonophagocytic Ab titer, and B-cell phenotype distribution were similar between vaccine-naive and vaccine-experienced elderly individuals (data not shown). These data suggest that age is the single most important factor in the shift in preimmunization phenotype distribution of PPSlabeled B cells. Most previous studies evaluating postvaccination alterations in B-cell phenotype examined unselected B-cell populations [9, 34, 35] , rather than antigen-selected B cells. Recently, Clutterbuck et al [36] studied the immune response to either PPV or pneumococcal conjugate vaccine (PCV) followed by PPV in adults aged 50-70 years. PPS-labeled B cells were obtained using biotinylated PPS/streptavidin beads, and cells were analyzed 1 month after vaccination. However, this phenotype analysis is not suitable for comparison to our study because of substantial differences in B-cell capture techniques and timing. We specifically analyzed PBMCs 7 days after vaccination, when the highest number of antigen-specific Ab-secreting cells are found in the peripheral circulation [37, 38] . We examined PPSspecific B cells 30 days after vaccination in 16 young adults and 8 elderly adults (unpublished observations). These studies demonstrated that, 30 days after vaccination, antigen-specific B cells are at preimmunization levels. In addition, the phenotype of PPS-specific B cells was not significantly different from the preimmunization phenotype in young, PPV-naive elderly individuals and previously immunized elderly individuals. These data suggest that, 30 days after vaccination, antigen-specific B cells are by and large absent from the peripheral circulation and reside elsewhere in the B-cell compartment. Findings of phenotype analysis obtained 30 days after vaccination were thus similar to those reported by Clutterbuck et al [36] . However, this time point is likely not an accurate representation of the cellular immune response to PPV, because it reflects the PBMCs rather than the bone marrow or spleen, which are more likely reservoirs of antigen-specific B cells 30 days after vaccination. We recognize that a limited number of elderly individuals were studied and that this group consisted of 10 PPV-naive and 4 PPV-experienced individuals (who were immunized >5 years previously). Although the number of individuals enrolled limits the power of our statistical analyses, we found no difference in immune response between the naive and experienced groups. These results are supported by recently reported studies of PCV13 in elderly individuals [39] .
The data presented here demonstrate decreased anti-PPS IgM Ab concentrations, OPA, and absolute and relative numbers of IgM + CD27 + B cells in elderly individuals, compared with young adults. Moreover, clinical studies have established the decreased protective efficacy of PPV in elderly individuals [2, 22] . We hypothesize a direct link between these observations, suggesting a critical role of PPS-specific IgM + CD27 + B cells in protective immunity against S. pneumoniae. The recent change in pneumococcal vaccination practices will let us study the immune response following pneumococcal conjugate vaccination in elderly and immunocompromised individuals. The analysis of the B-cell repertoire will allow us to dissect differences between PCV and PPV responses at a cellular level, providing increased insight into the role of IgM and switched memory B cells in protective immunity.
Notes
